EA
AIMT
Emerald Advisers’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-525,423
| Closed | -$8.78M | – | 372 |
|
2020
Q2 | $8.78M | Sell |
525,423
-1,727
| -0.3% | -$28.9K | 0.38% | 93 |
|
2020
Q1 | $7.6M | Sell |
527,150
-82,373
| -14% | -$1.19M | 0.44% | 86 |
|
2019
Q4 | $20.4M | Sell |
609,523
-988
| -0.2% | -$33.1K | 0.86% | 42 |
|
2019
Q3 | $12.8M | Sell |
610,511
-230,020
| -27% | -$4.82M | 0.6% | 68 |
|
2019
Q2 | $17.5M | Sell |
840,531
-12,460
| -1% | -$259K | 0.7% | 54 |
|
2019
Q1 | $19.1M | Buy |
852,991
+111,245
| +15% | +$2.49M | 0.78% | 50 |
|
2018
Q4 | $17.7M | Buy |
741,746
+255,080
| +52% | +$6.1M | 0.87% | 46 |
|
2018
Q3 | $13.3M | Buy |
486,666
+36,230
| +8% | +$988K | 0.49% | 92 |
|
2018
Q2 | $12.1M | Sell |
450,436
-8,204
| -2% | -$221K | 0.46% | 97 |
|
2018
Q1 | $14.6M | Sell |
458,640
-9,473
| -2% | -$302K | 0.59% | 76 |
|
2017
Q4 | $17.7M | Sell |
468,113
-73,922
| -14% | -$2.8M | 0.68% | 59 |
|
2017
Q3 | $13.4M | Sell |
542,035
-16,911
| -3% | -$419K | 0.55% | 75 |
|
2017
Q2 | $11.5M | Sell |
558,946
-24,620
| -4% | -$506K | 0.48% | 84 |
|
2017
Q1 | $12.7M | Sell |
583,566
-189,429
| -25% | -$4.12M | 0.52% | 79 |
|
2016
Q4 | $15.8M | Buy |
772,995
+308,631
| +66% | +$6.31M | 0.67% | 58 |
|
2016
Q3 | $6.97M | Buy |
464,364
+193,854
| +72% | +$2.91M | 0.31% | 114 |
|
2016
Q2 | $2.93M | Buy |
270,510
+450
| +0.2% | +$4.87K | 0.14% | 175 |
|
2016
Q1 | $3.66M | Sell |
270,060
-298
| -0.1% | -$4.04K | 0.18% | 151 |
|
2015
Q4 | $4.99M | Buy |
270,358
+229,218
| +557% | +$4.23M | 0.24% | 125 |
|
2015
Q3 | $1.04M | Buy |
+41,140
| New | +$1.04M | 0.05% | 249 |
|